Diabetic Foot Ulcers
Diabetic foot ulcers are a major complication of diabetes characterized by the breakdown of the skin and sometimes deeper tissues of the foot, leading to sore formation. This condition occurs due to factors such as decreased sensation, impaired wound healing, abnormal pressure, and peripheral neuropathies, often resulting in secondary complications like infections, gangrene, or even amputation.
Health Outcomes
- Accelerated Lesion Repair
- Accelerated Wound Healing
- Delayed Onset of Infection
- Enhanced Healing Process
- Enhanced Wound Healing
- Enhanced Wound Healing in Infections
- Improved Abscess Cure Rate
- Improved Adhesion Characteristics
- Improved Angiogenesis
- Improved Angiogenic Biomarker
- Improved Blood Flow
- Improved Blood Vessel Growth
- Improved Burn Healing
- Improved Diabetic Foot Ulcer Healing
- Improved Endothelial Cell Migration
- Improved Healing of Extraction Socket
- Improved Lesion Regression
- Improved Osseointegration
- Improved Overall Patient Outcomes
- Improved Phagocytic Capacity of Polymorphonuclear Cells
- Improved Phagocytic Function
- Improved Scar Appearance
- Improved Skin Perfusion
- Improved Skin Re-Epithelialization
- Improved Skin Regeneration
- Improved Tissue Healing
- Improved Tissue Oxygen Saturation Index
- Improved Tissue Regeneration
- Improved Wound Healing
- Improved Wound Healing In Vivo
- Improved Wound Healing in Infected Wounds
- Improved Wound Repair
- Increased Angiogenesis
- Increased CD34+ Cell Recruitment
- Increased Collagen Synthesis
- Increased Complete Ulcer Healing Frequency
- Increased Cytoprotection Against Tissue Damage
- Increased Healing Rate
- Increased Inter-ulcer Interval
- Increased Invasive Interventions Requirement
- Increased Late-Onset Sepsis Incidence
- Increased Proportion of Aerobic and Anaerobic Bacteria
- Increased Rate of Recurrent Bacteremia
- Increased Tissue Necrosis
- Increased Ulcer Healing Score
- No Change in Anthropometric Parameters
- Persistent Diseased Sites
- Reduced Advanced Glycation End Product Level
- Reduced Biofilm Formation
- Reduced Clinical Wound Pathogen Growth
- Reduced Debridement Time
- Reduced Diabetic Complications
- Reduced Diabetic Peripheral Neuropathy
- Reduced Epithelial Breakdown
- Reduced Glucotoxicity
- Reduced Glycation End Product Accumulation
- Reduced HIF-1α Level
- Reduced Healing Time
- Reduced Hyaluronan Level
- Reduced Incidence of Clinical Sepsis
- Reduced Incidence of Footpad Lesions
- Reduced Incidence of Ulcers
- Reduced Inflammation Around Wounds
- Reduced Lesion Healing Time
- Reduced Lesion Size
- Reduced Localized Infection
- Reduced Matrix Metalloproteinase-1 Level
- Reduced Necrotic Cell Infiltration
- Reduced Pathogen Adherence
- Reduced Pathogenic Bacterial Species Level
- Reduced Pressure Injury Occurrence
- Reduced Redness at Surgical Site
- Reduced Shear Force
- Reduced Skin Complication
- Reduced Staphylococcus Aureus Infection
- Reduced Tissue Inhibitor of Metalloproteinase 1 Level
- Reduced Ulcer Count
- Reduced Ulcer Formation
- Reduced Ulcer Healing Time
- Reduced Ulcer Number
- Reduced Ulcer Severity
- Reduced Ulcer Size
- Reduced Wound Area
- Reduced Wound Healing Time
- Reduced Wound Infection
- Reduced Wound Length
- Reduction of Diabetes-Induced Organ Damage
- Stabilized Hemoglobin A1c Level
- Unchanged Serum Metabolite Levels